Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Jupiter Life Line HospitalsNSE:JLHL +0.83%94 5-Year Yield-on-Cost % is 0.07 as of Sep. 22, 2026, which is at its 10-year median of 0.07. GuruFocus rates NSE:JLHL with a GF Score™ of 94/100 and a GF Value™ of ₹355.71 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 281 Healthcare Providers & Services companies, Jupiter Life Line Hospitals ranks worse than 99.29% on this metric.
The historical rank and industry rank for Jupiter Life Line Hospitals's 5-Year Yield-on-Cost % or its related term are showing as below:
NSE:JLHL'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.06 Med: 0.07 Max: 0.14
Current: 0.07
During the past 7 years, Jupiter Life Line Hospitals's highest Yield on Cost was 0.14. The lowest was 0.06. And the median was 0.07.
NSE:JLHL's 5-Year Yield-on-Cost % is ranked worse than 99.29% of 281
companies
in the Healthcare Providers & Services industry
Industry Median: 2.95
vs NSE:JLHL: 0.07
Jupiter Life Line Hospitals (NSE:JLHL) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Jupiter Life Line Hospitals 5-Year Yield-on-Cost % Related Terms
NSE:JLHL vs HCA, THC, EHC: 5-Year Yield-on-Cost % Comparison
For the Medical Care Facilities subindustry, Jupiter Life Line Hospitals's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jupiter Life Line Hospitals 5-Year Yield-on-Cost % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Jupiter Life Line Hospitals's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Jupiter Life Line Hospitals's 5-Year Yield-on-Cost % falls into.
Jupiter Life Line Hospitals 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Jupiter Life Line Hospitals (NSE:JLHL) has a 5-Year Yield-on-Cost % of 0.07 as of Sep. 22, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Jupiter Life Line Hospitals and its competitors. This is near median its historical median of 0.07. Over the past decade, Jupiter Life Line Hospitals' 5-Year Yield-on-Cost % has ranged from 0.06 to 0.14. According to the industry distribution chart, Jupiter Life Line Hospitals ranks #279 out of 281 companies in the Healthcare Providers & Services industry, placing it in the top 99.3%.
Is Jupiter Life Line Hospitals' 5-Year Yield-on-Cost % too high?
Jupiter Life Line Hospitals' current 5-Year Yield-on-Cost % of 0.07 is near median its 10-year median of 0.07. Over the past 10 years, this metric has ranged from a low of 0.06 to a high of 0.14. The Healthcare Providers & Services industry median 5-Year Yield-on-Cost % is 2.95. Jupiter Life Line Hospitals' value of 0.07 is 97.6% below this industry median. Based on the distribution chart, Jupiter Life Line Hospitals ranks #279 out of 281 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Jupiter Life Line Hospitals has a GF Score™ of 94/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Jupiter Life Line Hospitals' 5-Year Yield-on-Cost % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Jupiter Life Line Hospitals ranks #279 out of 281 companies for 5-Year Yield-on-Cost %. This places Jupiter Life Line Hospitals in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.95. Jupiter Life Line Hospitals' value of 0.07 is 97.6% below this benchmark. Historically, Jupiter Life Line Hospitals' own 5-Year Yield-on-Cost % has ranged from 0.06 to 0.14 over the past decade. While the company's 10-year median is 0.07 vs. the industry median of 2.95, Jupiter Life Line Hospitals has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Healthcare Providers & Services company?
The median 5-Year Yield-on-Cost % among Healthcare Providers & Services companies is 2.95, based on 281 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jupiter Life Line Hospitals's current 5-Year Yield-on-Cost % of 0.07 is 97.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Jupiter Life Line Hospitals and its competitors. For the Healthcare Providers & Services industry, the median 5-Year Yield-on-Cost % is 2.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jupiter Life Line Hospitals's current 5-Year Yield-on-Cost % is 0.07, which is near median its own 10-year median of 0.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jupiter Life Line Hospitals stock overvalued right now?
Based on GuruFocus' analysis, Jupiter Life Line Hospitals (NSE:JLHL) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹355.71, compared to a current price of ₹275.55 — trading 22.5% below its estimated fair value. The current 5-Year Yield-on-Cost % is 0.07, which is near median its 10-year median of 0.07 and 97.6% below the Healthcare Providers & Services industry median of 2.95. Jupiter Life Line Hospitals' overall GF Score™ is 94/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Jupiter Life Line Hospitals (NSE:JLHL), the current 5-Year Yield-on-Cost % is 0.07 as of Sep. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jupiter Life Line Hospitals (NSE:JLHL) Overvalued in 2026?
Based on GuruFocus' analysis, Jupiter Life Line Hospitals stock appears to be undervalued.
The current stock price of ₹275.55 is trading 22.5% below its estimated GF Value™ of ₹355.71.
GuruFocus considers Jupiter Life Line Hospitals to be Modestly Undervalued.
Key valuation signals for NSE:JLHL:
5-Year Yield-on-Cost %: 0.07 (near median its 10-year median of 0.07)
GF Value™: ₹355.71 vs. price of ₹275.55 (22.5% below fair value)
Industry Position: 97.6% below the Healthcare Providers & Services median (#279 of 281)
No single metric tells the full story. See the NSE:JLHL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jupiter Life Line Hospitals Ltd is a key multi-specialty tertiary and quaternary healthcare provider. The Company operates in one business and geographical segment that is Medical and Healthcare Services in India. The Hospital revenue comprises of fees charged for inpatient and outpatient hospital services and other hospital services. Services include charges for accommodation, operation theatre, medical professional services, equipment, radiology, laboratory, and pharmaceutical goods used for treating patients.
94GF Score
Get the complete analysis for NSE:JLHL
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:JLHL has been successfully added to your 
